Lancet Haematology最新文献

筛选
英文 中文
Equivalence in clinical assessment of iron status requires ferritin assay standardisation before harmonisation of ferritin reference intervals. 要实现铁状况临床评估的等效性,需要在统一铁蛋白参考区间之前实现铁蛋白测定的标准化。
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 DOI: 10.1016/S2352-3026(24)00245-X
Dorine W Swinkels, Marith van Schrojenstein Lantman, Hanke L Matlung, Cas Weykamp, Marc Thelen
{"title":"Equivalence in clinical assessment of iron status requires ferritin assay standardisation before harmonisation of ferritin reference intervals.","authors":"Dorine W Swinkels, Marith van Schrojenstein Lantman, Hanke L Matlung, Cas Weykamp, Marc Thelen","doi":"10.1016/S2352-3026(24)00245-X","DOIUrl":"10.1016/S2352-3026(24)00245-X","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":"11 10","pages":"e721"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-BCMA/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1 + 1 greater than 2? 抗BCMA/GPRC5D双特异性CAR T细胞治疗复发或难治性多发性骨髓瘤:1+1大于2吗?
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 Epub Date: 2024-07-23 DOI: 10.1016/S2352-3026(24)00205-9
Chenggong Li, Heng Mei
{"title":"Anti-BCMA/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1 + 1 greater than 2?","authors":"Chenggong Li, Heng Mei","doi":"10.1016/S2352-3026(24)00205-9","DOIUrl":"10.1016/S2352-3026(24)00205-9","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":" ","pages":"e712-e713"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141767777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma. 伊沙妥昔单抗联合卡非佐米-地塞米松治疗复发性多发性骨髓瘤。
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 Epub Date: 2024-07-24 DOI: 10.1016/S2352-3026(24)00220-5
Dai Maruyama, Nobuhiko Yamauchi
{"title":"Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma.","authors":"Dai Maruyama, Nobuhiko Yamauchi","doi":"10.1016/S2352-3026(24)00220-5","DOIUrl":"10.1016/S2352-3026(24)00220-5","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":" ","pages":"e710-e711"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Haematol 2024; 10: e879-89. Lancet Haematol 2024; 10: e879-89 更正。
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 Epub Date: 2024-08-12 DOI: 10.1016/S2352-3026(24)00252-7
{"title":"Correction to Lancet Haematol 2024; 10: e879-89.","authors":"","doi":"10.1016/S2352-3026(24)00252-7","DOIUrl":"10.1016/S2352-3026(24)00252-7","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":" ","pages":"e723"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study. 核工作人员低水平电离辐射照射(INWORKS)后白血病、淋巴瘤和多发性骨髓瘤的死亡率:国际队列研究的最新发现。
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 Epub Date: 2024-08-30 DOI: 10.1016/S2352-3026(24)00240-0
Klervi Leuraud, Dominique Laurier, Michael Gillies, Richard Haylock, Kaitlin Kelly-Reif, Stephen Bertke, Robert D Daniels, Isabelle Thierry-Chef, Monika Moissonnier, Ausrele Kesminiene, Mary K Schubauer-Berigan, David B Richardson
{"title":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study.","authors":"Klervi Leuraud, Dominique Laurier, Michael Gillies, Richard Haylock, Kaitlin Kelly-Reif, Stephen Bertke, Robert D Daniels, Isabelle Thierry-Chef, Monika Moissonnier, Ausrele Kesminiene, Mary K Schubauer-Berigan, David B Richardson","doi":"10.1016/S2352-3026(24)00240-0","DOIUrl":"10.1016/S2352-3026(24)00240-0","url":null,"abstract":"<p><strong>Background: </strong>A major update to the International Nuclear Workers Study (INWORKS) was undertaken to strengthen understanding of associations between low-dose exposure to penetrating forms of ionising radiation and mortality. Here, we report on associations between radiation dose and mortality due to haematological malignancies.</p><p><strong>Methods: </strong>We assembled a cohort of 309 932 radiation-monitored workers (269 487 [87%] males and 40 445 [13%] females) employed for at least 1 year by a nuclear facility in France (60 697 workers), the UK (147 872 workers), and the USA (101 363 workers). Workers were individually monitored for external radiation exposure and followed-up from Jan 1, 1944, to Dec 31, 2016, accruing 10·72 million person-years of follow-up. Radiation-mortality associations were quantified in terms of the excess relative rate (ERR) per Gy of radiation dose to red bone marrow for leukaemia excluding chronic lymphocytic leukaemia (CLL), as well as subtypes of leukaemia, myelodysplastic syndromes, non-Hodgkin and Hodgkin lymphomas, and multiple myeloma. Estimates of association were obtained using Poisson regression methods.</p><p><strong>Findings: </strong>The association between cumulative dose to red bone marrow, lagged 2 years, and leukaemia (excluding CLL) mortality was well described by a linear model (ERR per Gy 2·68, 90% CI 1·13 to 4·55, n=771) and was not modified by neutron exposure, internal contamination monitoring status, or period of hire. Positive associations were also observed for chronic myeloid leukaemia (9·57, 4·00 to 17·91, n=122) and myelodysplastic syndromes alone (3·19, 0·35 to 7·33, n=163) or combined with acute myeloid leukaemia (1·55, 0·05 to 3·42, n=598). No significant association was observed for acute lymphoblastic leukaemia (4·25, -4·19 to 19·32, n=49) or CLL (0·20, -1·81 to 2·21, n=242). A positive association was observed between radiation dose and multiple myeloma (1·62, 0·06 to 3·64, n=527) whereas minimal evidence of association was observed between radiation dose and non-Hodgkin lymphoma (0·27, -0·61 to 1·39, n=1146) or Hodgkin lymphoma (0·60, -3·64 to 4·83, n=122) mortality.</p><p><strong>Interpretation: </strong>This study reports a positive association between protracted low dose exposure to ionising radiation and mortality due to some haematological malignancies. Given the relatively low doses typically accrued by workers in this study (16 mGy average cumulative red bone marrow dose) the radiation attributable absolute risk of leukaemia mortality in this population is low (one excess death in 10 000 workers over a 35-year period). These results can inform radiation protection standards and will provide input for discussions on the radiation protection system.</p><p><strong>Funding: </strong>National Cancer Institute, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Institut de Radioprotection et de Sûreté Nucléaire, Or","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":" ","pages":"e761-e769"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood cell defence against pathogens. 血细胞对病原体的防御
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 DOI: 10.1016/S2352-3026(24)00286-2
Simon T Abrams, Cheng-Hock Toh
{"title":"Blood cell defence against pathogens.","authors":"Simon T Abrams, Cheng-Hock Toh","doi":"10.1016/S2352-3026(24)00286-2","DOIUrl":"https://doi.org/10.1016/S2352-3026(24)00286-2","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":"11 10","pages":"e728"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lines of the haematology community. 血液病学界的路线。
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 DOI: 10.1016/S2352-3026(24)00287-4
Jacqueline Del Castillo
{"title":"Lines of the haematology community.","authors":"Jacqueline Del Castillo","doi":"10.1016/S2352-3026(24)00287-4","DOIUrl":"https://doi.org/10.1016/S2352-3026(24)00287-4","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":"11 10","pages":"e728"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiotherapy for haematological malignancies. 血液恶性肿瘤的放射治疗。
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 DOI: 10.1016/S2352-3026(24)00247-3
Edward Christopher Dee, James Fan Wu, Erin Jay G Feliciano, Luisa E Jacomina, Joachim Yahalom
{"title":"Radiotherapy for haematological malignancies.","authors":"Edward Christopher Dee, James Fan Wu, Erin Jay G Feliciano, Luisa E Jacomina, Joachim Yahalom","doi":"10.1016/S2352-3026(24)00247-3","DOIUrl":"10.1016/S2352-3026(24)00247-3","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":"11 10","pages":"e721-e722"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood cancer: the bold dancer. 血癌:大胆的舞者
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 DOI: 10.1016/S2352-3026(24)00290-4
Eleanor Philpotts
{"title":"Blood cancer: the bold dancer.","authors":"Eleanor Philpotts","doi":"10.1016/S2352-3026(24)00290-4","DOIUrl":"10.1016/S2352-3026(24)00290-4","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":"11 10","pages":"e726-e727"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood cell defence against pathogens. 血细胞对病原体的防御
IF 15.4 1区 医学
Lancet Haematology Pub Date : 2024-10-01 DOI: 10.1016/S2352-3026(24)00286-2
Simon T Abrams, Cheng-Hock Toh
{"title":"Blood cell defence against pathogens.","authors":"Simon T Abrams, Cheng-Hock Toh","doi":"10.1016/S2352-3026(24)00286-2","DOIUrl":"https://doi.org/10.1016/S2352-3026(24)00286-2","url":null,"abstract":"","PeriodicalId":48726,"journal":{"name":"Lancet Haematology","volume":"11 10","pages":"e728"},"PeriodicalIF":15.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信